戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nized whole blood from human volunteers on a membrane oxygenator.
2  the patient circuit and passed it through a membrane oxygenator.
3 ed by adjusting the CO2 gas flow through the membrane oxygenator.
4 91.5% and 25% by placement on extracorporeal membrane oxygenator.
5                                            A membrane oxygenator (0.65 m) was inserted within the hem
6 icrofluidic chamber mimicking a hollow fiber membrane oxygenator and validate the model against these
7                       The different types of membrane oxygenators and pumps did not significantly alt
8 n circuit consisted of a centrifugal pump, a membrane oxygenator, and a heat exchanger.
9 ion system consisted of a blood reservoir, a membrane oxygenator, and a nonocclusive roller pump.
10 taken immediately proximal and distal to the membrane oxygenator at 5 mins, 1 hr, and 3 hrs after the
11 nd oxygenated using a bespoke extracorporeal membrane oxygenator circuit before return to the donor.
12                The use of the extracorporeal membrane oxygenator (ECMO) for postoperative cardiac pat
13 utcomes in patients receiving extracorporeal membrane oxygenator (ECMO) support.
14 e life continuation relies on extracorporeal membrane oxygenator (ECMO).
15                            The flow from the membrane oxygenator either returned directly to the pati
16    They had a significantly higher number of membrane oxygenator failures, changes to their cannulati
17 n an ovine model of ARDS and ECMO can impair membrane oxygenator function and does not improve oxygen
18 ygenator; spent more hours on extracorporeal membrane oxygenator; had significantly higher heparin-in
19               Closed system circuits using a membrane oxygenator have partially met these requirement
20 he introduction of arterial-line filters and membrane oxygenators, have led to a reduction of both mi
21  and there is no uptake of morphine onto the membrane oxygenator of the ECMO circuit.
22 enia-related thrombosis among extracorporeal membrane oxygenator patients at our institution is relat
23  a defined high-risk group of extracorporeal membrane oxygenator patients may be needed.
24                    Ninety-six extracorporeal membrane oxygenator patients met the inclusion criteria.
25 ollected prospectively on all extracorporeal membrane oxygenator patients.
26 is not an optimal strategy in extracorporeal membrane oxygenator patients.
27 ecirculated for 2 hours in an extracorporeal membrane oxygenator perfusion circuit at 37 degrees C.
28 thromboembolic event while on extracorporeal membrane oxygenator (prevalence of heparin-induced throm
29 r; all underwent venoarterial extracorporeal membrane oxygenator; spent more hours on extracorporeal
30 innervated dog hindlimb perfused with a pump-membrane oxygenator system, the oxygen delivery (DO(2))
31 15 mmol) was injected just downstream of the membrane oxygenator; the lithium ion concentration-time
32 servoir and in the flow just upstream of the membrane oxygenator using lithium selective electrodes.
33 emoval rate (p = 0.083) were higher when the membrane oxygenator was placed upstream of the hemofilte